Category Archives: Research
Neuromodulation Therapy May Improve Treatment-Resistant Depression
A high dose of intermittent theta-burst stimulation with functional-connectivity-guided targeting outperformed sham stimulation for treatment-resistant depression.
Left Dorsolateral Prefrontal Cortex rTMS in Alleviating MTBI Related Headaches and Depressive Symptoms
Persistent mild traumatic brain injury related headache (MTBI-HA) represents a neuropathic pain state.
Subthreshold Stimulation Intensity Is Associated With Greater Clinical Efficacy Of Intermittent Theta-burst Stimulation Priming for Major Depressive Disorder
Intermittent theta-burst stimulation priming (iTBS-P) can improve clinical outcome of patients with Major Depressive Disorders.
Functional Magnetic Resonance Imaging–Guided Personalization of Transcranial Magnetic Stimulation Treatment for Depression
Antidepressant outcomes to repetitive transcranial magnetic stimulation (rTMS) are better when stimulation is serendipitously delivered to the prefrontal cortex.
Treatment Resistant Depression: Case Report
rTMS treatment for Major Depressive Disorder MDD involves stimulation of the dorsolateral prefrontal cortex which plays an important role in cognitive function and mood.
Study Uses Non-invasive Technique To Help Veterans With Depression, Concussion
Promising studies using repetitive T to help veterans and active-duty service members living with depression, post-traumatic stress disorder (PTSD), and other lasting consequences of concussion.
Pilot Study: New Approach to Help Adults with Autism and Depression
Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.
Targeting Brain Circuits in TMS May Relieve Specific Symptoms of Depression
Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.